Table 1 HrHPV type-specific prevalence rates in high-grade cervical intraepithelial neoplasia vs squamous cell carcinoma
All infections a ,b | Single infections a | |||||||
|---|---|---|---|---|---|---|---|---|
SCC | CIN2/3 | SCC∼>CIN2/3 | SCC | CIN2/3 | SCC∼>CIN2/3 | |||
n =84 | n =139 | n =74 | n =126 | |||||
Type | N (%) | N (%) | OR (95% CI) | P | N (%) | N (%) | OR (95% CI) | P |
16 | 58 (69.9) | 83 (59.7) | 1.5 (0.8–3.1) | 0.229 | 55 (74.3) | 75 (59.5) | 2.1 (1.0–4.5) | 0.065 |
18 | 10 (12.0) | 4 (2.9) | 8.3 (1.9–36) | 0.002 | 8 (10.8) | 3 (2.4) | 10 (2.0–52) | 0.005 |
n16/n18 | 17 (20.5) | 51 (36.7) | 0.4 (0.2–0.8) | 0.009 | 11 (14.9) | 47 (37.3) | 0.2 (0.1–0.5) | 0.001 |
31 | 6 (7.2) | 18 (12.9) | 0.4 (0.1–1.5) | 0.145 | 3 (4.1) | 11 (8.7) | 0.5 (0.1–2.1) | 0.371 |
33 | 3 (3.6) | 8 (5.8) | 1.0 (0.2–4.6) | 0.959 | 1 (1.4) | 7 (5.6) | 0.4 (0.1–3.4) | 0.390 |
35 | 2 (2.4) | 5 (3.6) | 0.2 (0.1–3.3) | 0.272 | ’ | 3 (2.4) | ’ | ’ |
39 | 4 (4.8) | ’ | ’ | ’ | 1 (1.4) | ’ | ’ | ’ |
45 | 5 (6.0) | 6 (4.3) | 0.8 (0.1–6.1) | 0.850 | 4 (5.4) | 3 (2.4) | 0.6 (0.1–8.1) | 0.701 |
51 | ’ | 4 (2.9) | ’ | ’ | ’ | 3 (2.4) | ’ | ’ |
52 | ’ | 16 (11.5) | ’ | ’ | ’ | 14 (11.1) | ’ | ’ |
56 | 2 (2.4) | 1 (0.7) | 1.6 (0.1–46) | 0.815 | 1 (1.4) | 1 (0.8) | 1.7 (0.1–28) | 0.705 |
58 | 2 (2.4) | 7 (5.0) | 1.6 (0.1–11) | 0.652 | 1 (1.4) | 4 (3.2) | 0.6 (0.1–9.0) | 0.738 |
59 | ’ | 1 (0.7) | ’ | ’ | ’ | 1 (0.8) | ’ | ’ |
66 | ’ | 1 (0.7) | ’ | ’ | ’ | ’ | ’ | ’ |
68 | ’ | ’ | ’ | ’ | ’ | ’ | ’ | ’ |
